Johnson & Johnson (JNJ)

Healthcare

$261.44

+1.93%

nightly snapshot · 10/11/2026

ALPHASCORE™ · B · Watch

ALPHASCORE

69

/ 100

B

WATCH

▲ 0 · 30D

KEY FUNDAMENTALS

P/E30.3

ROE32.9%

NET MARGIN28.5%

GROSS MARGIN67.9%

MKT CAP$630.04B

loading full analysis…

DAILY BRIEF

Johnson & Johnson posts an AlphaScore of 69/100 within the Healthcare sector as of October 11, 2026. Important fundamentals include a high return on equity (ROE) of 32.87% and a strong net margin of 28.46%. A prominent strength is its high ROE, showing excellent efficiency in utilizing equity to generate net income. A potential risk is its elevated price-to-earnings (PE) ratio of 30.29. Evidence is limited to the provided record.

Written 11/10/2026, 00:23:45 UTC · Snapshot 11/10/2026